Pricing
  1. US-listed companies
  2. SOLENO THERAPEUTICS INC
  3. Financials
  4. Return on equity (%)

SOLENO THERAPEUTICS INC (SLNO)

Market cap
$1.9B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-87.3+88.05%
Dec 31, 2023-46.4-72.84%
Dec 31, 2022-171+75.26%
Dec 31, 2021-97.6+19.81%
Dec 31, 2020-81.5-39.97%
Dec 31, 2019-135.7+189.75%
Dec 31, 2018-46.8-55.21%
Dec 31, 2017-104.5-71.15%
Dec 31, 2016-362.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat